首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1629889

全球先進傷口護理與閉合市場 - 2025-2033

Global Advanced Wound Care and Closure Market - 2025-2033

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年，全球先進傷口護理和閉合市場規模達到215億美元，預計2033年將達到345億美元，2025-2033年預測期間複合年成長率為4.8%。

高級傷口護理和閉合是一個專門的醫療保健領域，專注於使用創新產品和技術來治療和管理急性和慢性傷口。它涉及使用泡沫、水膠體、藻酸鹽和抗菌劑等敷料來創造最佳的癒合環境，預防感染並促進組織再生。縫合線、釘書釘、組織黏合劑和止血劑等醫療解決方案用於安全閉合傷口並支持自然癒合過程。這些先進的解決方案提供有針對性的治療，以促進康復、最大限度地減少併發症並改善患者的治療效果。它對於處理慢性傷口、手術傷口、外傷和燒傷病例至關重要。

市場動態：

驅動程式和限制

慢性傷口盛行率上升

由於糖尿病、肥胖和血管疾病引起的慢性傷口（例如糖尿病足潰瘍、靜脈性腿部潰瘍和壓瘡）的盛行率不斷增加，全球先進傷口護理和閉合市場正在蓬勃發展。這些情況會損害傷口的自然癒合過程，因此需要先進的解決方案。人口老化推動了對泡沫敷料、水膠體和抗菌敷料等創新傷口護理產品的需求，由於皮膚彈性下降和再生能力較慢，老年人更容易患慢性傷口。這些產品提供最佳的水分平衡，降低感染風險，促進更快的癒合，進而推動全球市場的成長。

例如，根據 Uintah Basin Healthcare 的數據，近 70 億美國人患有慢性傷口，其中 20 億人患有糖尿病足潰瘍。四分之一的家庭有一名家庭成員患有慢性傷口。長期不癒合的傷口會增加感染、住院或截肢的風險。隨著人口老化以及肥胖、糖尿病和心臟病等疾病的增加，傷口護理的普及率預計在未來 5-10 年內每年將以 2% 的速度成長。

醫療保健專業人員的意識和培訓有限

全球先進傷口護理和閉合市場因醫療保健專業人員的意識和培訓有限而受到阻礙，特別是在發展中國家。由於缺乏對先進傷口護理產品及其應用的接觸，經常使用傳統方法。這阻礙了生物活性敷料、組織工程產品和先進閉合裝置等創新解決方案的採用。一些先進傷口護理技術的複雜性需要專門的訓練。培訓計劃不足和獲得教育資源的機會有限加劇了這種知識差距，阻礙了先進傷口護理產品的滲透並影響患者護理質量，最終減緩了市場的成長潛力。

Advanced wound care and closure is a specialized healthcare field that focuses on treating and managing acute and chronic wounds using innovative products and techniques. It involves the use of dressings like foam, hydrocolloid, alginate, and antimicrobial to create optimal healing environments, prevent infections, and promote tissue regeneration. Medical solutions like sutures, staples, tissue adhesives, and hemostatic agents are used to securely close wounds and support the natural healing process. These advanced solutions offer targeted therapies to enhance recovery, minimize complications, and improve patient outcomes. It is crucial for managing chronic wounds, surgical wounds, traumatic injuries, and burn cases.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Chronic Wounds

The global advanced wound care and closure market is thriving due to the increasing prevalence of chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, caused by diabetes, obesity, and vascular diseases. These conditions impair the natural wound healing process, necessitating advanced solutions. The demand for innovative wound care products, such as foam dressings, hydrocolloids, and antimicrobial dressings, is fueled by the aging population, who are more susceptible to chronic wounds due to reduced skin elasticity and slower regenerative capacity. These products provide optimal moisture balance, reduce infection risks, and promote faster healing, thereby driving market growth globally.

For instance, according to Uintah Basin Healthcare, Nearly 7 Billion Americans suffer from chronic wounds, including 2 Billion with diabetic foot ulcers. 1 in 4 families has a family member with a chronic wound. Long-term non-healing wounds increase the risk of infection, hospitalization, or amputation. As the population ages and conditions like obesity, diabetes, and heart disease increase, the prevalence of wound care is expected to grow by 2% per year over the next 5-10 years.

Limited Awareness and Training among Healthcare Professionals

The global advanced wound care and closure market is hindered by limited awareness and training among healthcare professionals, particularly in developing countries. Traditional methods are often used due to a lack of exposure to advanced wound care products and their applications. This prevents the adoption of innovative solutions like bioactive dressings, tissue-engineered products, and advanced closure devices. The sophisticated nature of some advanced wound care technologies requires specialized training. Inadequate training programs and limited access to educational resources exacerbate this knowledge gap, hindering the penetration of advanced wound care products and affecting patient care quality, ultimately slowing the market's growth potential.

Segment Analysis

The global advanced wound care and closure market is segmented based on product type, wound type, end user and region.

Product Type:

Foam Dressing segment from advanced wound care products is expected to dominate the Advanced Wound Care and Closure market share

The foam dressing segment from advanced wound care products holds a major portion of the advanced wound care and closure market share and is expected to continue to hold a significant portion of the advanced wound care and closure market share during the forecast period.

Foam dressings are a crucial component in the global wound care and closure market, providing a moist environment for managing various wounds. They are highly absorbent, ideal for moderate to heavy exudate wounds like diabetic foot ulcers and pressure ulcers. They offer cushioning, protection, and minimize pain during dressing changes. Foam dressings are versatile, suitable for both hospital and home care settings, driving their global adoption. The increasing prevalence of chronic conditions like diabetes and obesity, along with the increasing number of surgeries worldwide, contribute to the growing demand for foam dressings. Their ease of use, high performance, and cost-effectiveness make them a cornerstone in advanced wound care, enhancing patient outcomes and accelerating the market's growth.

For instance, in January 2023, Smith+Nephew has published data on its ALLEVYN LIFE Dressing, which shows a novel mechanism of action for pressure injury prevention (PIP). The study, published in the International Wound Journal, found that the dressing's independent and non-bonded internal layers allow for a layer-on-layer sliding phenomenon, allowing for the dissipation of mechanical energy that could otherwise be transferred to the patient. This results in the layer-on-layer frictional sliding of ALLEVYN LIFE Dressing absorbing 30-45% of the mechanical energy, potentially reducing pressure injury incidence in the patient's skin and underlying soft tissues.

End User:

Hospitals segment is the fastest-growing segment in Advanced Wound Care and Closure market share

The hospitals segment is the fastest-growing segment in the advanced wound care and closure market share and is expected to hold the market share over the forecast period.

Hospitals are the primary treatment centers for complex and chronic wounds, including diabetic foot ulcers, surgical wounds, pressure ulcers, and burn injuries. The growing number of hospital admissions for these conditions and the increasing incidence of surgeries and trauma cases fuel the demand for advanced wound care solutions.

Moreover, hospitals are equipped with the necessary infrastructure and expertise to administer advanced wound care therapies, such as bioactive dressings, hydrocolloids, and tissue-engineered products. Adoption of minimally invasive wound closure technologies, such as tissue adhesives and hemostatic agents, supports faster healing and reduces recovery times, enhancing patient outcomes. The extensive use of advanced wound care products in hospitals boosts their availability and accelerates innovation in wound management solutions, making them a key driver in the market's growth.

Geographical Analysis

North America is expected to hold a significant position in the Advanced Wound Care and Closure market share

North America holds a substantial position in the advanced wound care and closure market and is expected to hold most of the market share due to its established healthcare infrastructure, high healthcare funding, and advanced medical technology adoption. The US is particularly affected by chronic conditions like diabetes, obesity, and cardiovascular diseases, leading to chronic wounds like diabetic foot ulcers and pressure ulcers. The increasing number of surgical procedures and aging population further increase the need for advanced wound closure solutions. The region's strong regulatory framework ensures product safety and efficacy, fostering consumer confidence and market growth. Additionally, reimbursement policies for advanced wound care products enhance their adoption by healthcare providers and patients, contributing significantly to the market's growth.

For instance, in January 2024, 3M Health Care's Medical Solutions Division has been awarded $34.2 Billion from the U.S. Army Medical Research Acquisition Activity to develop new infection prevention, wound management, and wound healing solutions. The program will focus on treatment strategies for austere settings, particularly mass casualty and delayed evacuation situations, as part of the Department of Defense Combat Casualty Care Capability Assessment. It will also assess biofilm control, biomarker monitoring, and healing in acute trauma situations.

Moreover, in September 2024, Solventum has launched the V.A.C. Peel and Place Dressing, an integrated dressing and drape that can be applied in less than two minutes and worn by patients for up to seven days. This is a significant improvement over traditional dressings for negative pressure wound therapy, which typically take more than two hours to apply.

Asia-Pacific is growing at the fastest pace in the Advanced Wound Care and Closure market

Asia-Pacific holds the fastest pace in the advanced wound care and closure market and is expected to hold most of the market share due to the due to economic development, improved healthcare infrastructure, and increased healthcare awareness. The rising incidence of chronic diseases like diabetes and hypertension, as well as the aging population in countries like China, India, and Japan, are driving demand for these solutions. However, challenges such as limited awareness and training among healthcare professionals persist, especially in rural areas. Despite these obstacles, the increasing number of healthcare facilities, rising disposable income, and government healthcare investments present significant opportunities for the advanced wound care market in the APAC region.

For instance, in July 2024, AMS BioteQ, a biotech company, has obtained a first-class medical device sales permit from Japan's PMDA for its "SIPSIP Foam Wound Dressing," a medical device with excellent anti-adhesion properties, high absorbency, and tissue regeneration capabilities. This is the first Taiwanese "cotton-based wound dressing" medical device to receive approval in Japan, marking a milestone in AMS BioteQ's global market expansion for its self-developed brand.

Competitive Landscape

The major global players in the advanced wound care and closure market include 3M Company, Integra LifeSciences Holdings Corporation, Baxter International Inc., Johnson & Johnson, Convatec Group plc, Essity Aktiebolag AB, Coloplast, Medtronic plc, B. Braun SE, Smith and Nephew plc and among others.

Key Developments

In August 2023, Healthium Medtech has launched TRUMASTM, a range of sutures designed to address challenges in minimal access surgeries. As India celebrates its 77th year of Independence, Healthium reaffirms its commitment to innovation in the Indian medtech landscape by introducing a revolutionary solution for suturing during minimal access procedures.

Emerging Players

The emerging players in the advanced wound care and closure market include KCI licensing, Inc, MiMedx Group, Inc, Organogenesis Holdings Inc, Axio Biosolutions, Hemostatix Medical Technologies, LLC and among Others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global advanced wound care and closure market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Wound Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Wound Type
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Chronic Wounds
- 4.1.2. Restraints
  - 4.1.2.1. Limited Awareness and Training among Healthcare Professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Advanced Wound Care *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Foam Dressings
- 6.2.4. Hydrocolloid Dressings
- 6.2.5. Hydrogel Dressings
- 6.2.6. Alginate Dressings
- 6.2.7. Collagen Dressings
- 6.2.8. Antimicrobial Dressings
- 6.2.9. Film Dressings
6.3. Wound Closure
- 6.3.1. Sutures
- 6.3.2. Hemostatic Agents
- 6.3.3. Staples
- 6.3.4. Tissue Adhesives, Sealants, and Glues

7. By Wound Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 7.1.2. Market Attractiveness Index, By Wound Type
7.2. Acute Wounds*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chronic Wounds

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Home Healthcare
8.5. Specialty Clinics

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. 3M Company *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Integra LifeSciences Holdings Corporation
11.3. Baxter International Inc
11.4. Johnson & Johnson
11.5. Convatec Group plc
11.6. Essity Aktiebolag AB
11.7. Coloplast
11.8. Medtronic Plc
11.9. B. Braun SE
11.10. Smith and Nephew Plc

LIST NOT EXHAUSTIVE